CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

U.S. employers lose an estimated $6 billion in productivity due to untreated menstrual health conditions and ...

With retail space in scarce supply, it has not been difficult to entice new tenants to small spaces like Medical Arts ...

Customers who have prescriptions at the Lansdowne store will be contacted directly — via letter, email and text messages — about transferring them to the store at 7095 Baltimore-Annapolis Road in the ...

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

BRIDGEPORT — CVS just opened a new Bridgeport location after Walgreens suddenly closed its doors at the site last year. The ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...